Nippon Paper Industries Co (3863) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
15 May, 2026Executive summary
Net sales for the fiscal year ended March 31, 2026, were ¥1,192.6 billion, up 0.9% year-over-year, driven by higher volumes in Daily-Life Products and investment effects.
Operating income increased 27.9% year-over-year to ¥25.2 billion, mainly due to improved profitability in overseas operations and normalization after prior-year maintenance.
Profit attributable to owners of parent was ¥11.7 billion, up 158.7% from the previous year.
Extraordinary income included gains from sales of investment securities and retirement benefits trust.
Comprehensive income reached ¥32.7 billion, an 89.6% increase year-over-year.
Financial highlights
FY2026/3 net sales: ¥1,192.6 billion (+0.9% YoY); operating income: ¥25.2 billion (+27.9% YoY); net income: ¥11.7 billion (+158.7% YoY).
EBITDA reached ¥92.0 billion; operating income margin improved to 2.1%.
Gross profit improved to ¥199.0 billion from ¥191.1 billion year-over-year.
Free cash flow was ¥31.4 billion; cash and equivalents at period end: ¥207.4 billion.
Basic earnings per share rose to ¥101.69 from ¥39.33 year-over-year.
Outlook and guidance
FY2027/3 forecast: net sales ¥1,220.0 billion (+2.3% YoY), operating income ¥25.0 billion (-0.8% YoY), net income ¥10.0 billion (-14.8% YoY).
Basic earnings per share forecast is ¥86.72.
Forecast incorporates a ¥7 billion negative impact from high raw material and fuel prices and Middle East uncertainty.
Price revisions for products are expected to continue to offset cost pressures.
Latest events from Nippon Paper Industries Co
- Operating and net income surged, driven by Daily-Life Products and overseas recovery.3863
Q3 20266 Feb 2026 - Profit rebounded in H1 FY2026/3, but full-year outlook trimmed on weak export and Australia demand.3863
Q2 20266 Nov 2025 - Operating income soared and net loss narrowed, with major restructuring and bond issuance planned.3863
Q1 202519 Aug 2025 - Net sales and operating profit rose, but net income plunged 80% on impairment losses.3863
Q4 202519 Aug 2025 - Sales and profits increased, with sustainability investments and a return to profitability.3863
Q3 202519 Aug 2025 - Sales were stable but profits fell sharply; H2 recovery expected, led by overseas operations.3863
Q2 202519 Aug 2025 - Earnings rose on Daily-Life Products and Energy growth, but FX losses weighed on comprehensive income.3863
Q1 202619 Aug 2025